Virology News and Research

Latest Virology News and Research

ID Biomedical awarded US$9.5 million to develop its cell culture-based influenza vaccine

ID Biomedical announced today that it has been awarded a US$9.5 million grant from the U.S. National Institutes of Health (NIH) to develop its cell culture-based influenza vaccine.

29 Sep 2004

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Scientists at the University of Aberdeen have been awarded £196,166 to help fund pioneering research, which is exploring a method of combating certain conditions and diseases such as asthma and multiple sclerosis.

29 Sep 2004

Last year over 36,000 Americans died from exposure to the flu

Another 200,000 people were hospitalized with symptoms of the illness. The flu and pneumonia (the most common complication of the flu) combined are the fifth leading cause of death among Americans age 65 and older.

29 Sep 2004

West Nile virus detected in blood donor

A Jackson County blood donor is the second person in Oregon to test positive for West Nile virus, according to public health and American Red Cross officials.

28 Sep 2004

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Chiron Corporation announced that president and chief executive officer Howard Pien will appear before the U.S. Senate Special Committee on Aging in Washington, D.C., today in a hearing titled, "Combating the Flu: Keeping Seniors Alive."

28 Sep 2004

Five new human cases of West Nile virus confirmed in Mississippi

The Mississippi State Department of Health has confirmed five additional human cases of West Nile virus - one in Hinds County, one in Lee County, one in Pike County and two in Rankin County residents.

26 Sep 2004

South African sales of MedMira rapid HIV tests begin

MedMira Inc., the international market leader in rapid flow- through diagnostic technology announced today that it has begun shipment of its MiraWell(TM) Rapid HIV Test to its distributor.

26 Sep 2004

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Researchers targeted Nef, a protein responsible for accelerating the development of acquired immunodeficiency syndrome, or AIDS. Nef was targeted with small molecules synthesized by the researchers – molecules that disrupted Nef’s interaction with other proteins.

26 Sep 2004

Study presents multiple lines of evidence against the proposed link between SV40 and human mesotheliomas

Mesothelioma is an aggressive cancer of the chest cavity that kills about 2000 people a year in the United States.

26 Sep 2004

Lassa Fever, not seen in US for 15 years re-emerges

The New Jersey Department of Health and Senior Services reported today that a 38-year-old Mercer County man died on August 28 from an acute viral disease called Lassa fever, a condition that is rare in the U.S., but endemic to West Africa.

23 Sep 2004

Allow genomic information to be freely available on the internet

This week’s lead editorial in THE LANCET discusses the benefits and potential risks of allowing genomic information to be freely available on the internet

23 Sep 2004

New combination of drugs results in fewer incidences of rejection in liver transplant patients

“The big advantage [of this combination of drugs] is that the incidence of rejection is significantly decreased,” he says. “These results could change the standard of care for liver transplant recipients.”

23 Sep 2004

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Dr Norelle Daly, from UQ’s Institute for Molecular Bioscience, is looking at the molecular structure of retrocyclin, a molecule with the ability to protect human cells from HIV infection.

23 Sep 2004

Research may lead to alternatives to antibiotic drugs for treating bacterial diseases

UCLA microbiologists report the discovery of a new class of genetic elements, similar to retroviruses, that operate in bacteria, allowing them to diversify their proteins to bind to a large variety of receptors.

23 Sep 2004

Potential new way to control drug-resistant bacteria

The researchers, who encountered this genetic property while working on an unrelated project, believe that this discovery could lead to the use of genetically engineered phages to treat bacterial infections that have become resistant to antibiotics.

23 Sep 2004

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Gaur acid is a natural skin secretion of the gaur, an Asian wild ox. Preliminary evidence suggests that this chemical discourages the landing and feeding of Aedes aegypti, a common mosquito that carries and transmits the yellow fever virus in some parts of the world.

23 Sep 2004

Virology News and Research

Latest Virology News and Research

ID Biomedical awarded US$9.5 million to develop its cell culture-based influenza vaccine

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Last year over 36,000 Americans died from exposure to the flu

West Nile virus detected in blood donor

Chiron CEO to appear before the U.S. Senate Special Committee on Aging

Five new human cases of West Nile virus confirmed in Mississippi

South African sales of MedMira rapid HIV tests begin

Researchers have successfully targeted an HIV protein that has eluded existing therapies

Study presents multiple lines of evidence against the proposed link between SV40 and human mesotheliomas

Lassa Fever, not seen in US for 15 years re-emerges

Allow genomic information to be freely available on the internet

New combination of drugs results in fewer incidences of rejection in liver transplant patients

Promising lead in developing anti-viral drugs with the potential to fight HIV and HSV

Research may lead to alternatives to antibiotic drugs for treating bacterial diseases

Potential new way to control drug-resistant bacteria

A naturally occurring chemical that may repel yellow fever mosquitoes can now be made in the laboratory

Nanowires could be used to sense thousands of different viruses

THC in marijuana may block the spread of forms of cancer causing herpes viruses

Research to halt the progress of chronic liver disease

Edible vaccine for HIV AIDS

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech